Maximus, Inc. $MMS Shares Acquired by Reinhart Partners LLC.

Reinhart Partners LLC. lifted its holdings in shares of Maximus, Inc. (NYSE:MMS) by 0.8% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 921,578 shares of the health services provider’s stock after acquiring an additional 7,722 shares during the period. Maximus makes up approximately 2.7% of Reinhart Partners LLC.’s investment portfolio, making the stock its 15th largest holding. Reinhart Partners LLC.’s holdings in Maximus were worth $84,206,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Norges Bank acquired a new position in Maximus during the 2nd quarter valued at approximately $47,886,000. Boston Partners increased its position in shares of Maximus by 113.6% in the 2nd quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock valued at $46,435,000 after acquiring an additional 349,529 shares during the period. Bank of New York Mellon Corp raised its stake in Maximus by 1.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 549,369 shares of the health services provider’s stock worth $38,566,000 after acquiring an additional 8,434 shares during the last quarter. Sio Capital Management LLC lifted its position in Maximus by 17.0% during the 2nd quarter. Sio Capital Management LLC now owns 548,086 shares of the health services provider’s stock worth $38,476,000 after acquiring an additional 79,734 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its stake in Maximus by 13.9% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 526,893 shares of the health services provider’s stock valued at $47,879,000 after purchasing an additional 64,207 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Maximus

In related news, insider Michelle F. Link sold 4,039 shares of the company’s stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total value of $350,746.76. Following the completion of the transaction, the insider owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. This represents a 17.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on MMS shares. Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Strong Buy”.

Maximus Stock Down 0.2%

Shares of MMS stock opened at $98.26 on Friday. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $98.83. The stock has a market cap of $5.35 billion, a P/E ratio of 17.67 and a beta of 0.56. The stock has a 50 day moving average of $86.85 and a 200 day moving average of $84.10. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.01). Maximus had a net margin of 5.87% and a return on equity of 25.23%. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.34 billion. During the same period last year, the firm earned $1.46 earnings per share. Maximus’s revenue for the quarter was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a dividend of $0.33 per share. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date is Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.3%. Maximus’s payout ratio is 23.74%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.